Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Learn how concave mirrors form images with a clear, step-by-step explanation that makes the mirror equation easy to ...

Discover how the equation of exchange links money supply, velocity of money, and price levels, influencing inflation and economic activity. Learn key formulas and impacts.

From certain variations of the Honda Civic Type R to some of Toyota's most potent offerings, many have never made it to ...

News headlines Vertex Pharmaceuticals is experiencing notable growth driven by its expanding pipeline and strong market interest, particularly in gene therapies. Recent clinical data and regulatory ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...